Cytek Biosciences, Inc. CTKB Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s total liabilities?
- Cytek Biosciences, Inc. (CTKB) reported total liabilities of $121.47M in Q1 2026.
- How has Cytek Biosciences, Inc.'s total liabilities changed year-over-year?
- Cytek Biosciences, Inc.'s total liabilities increased by 18.0% year-over-year, from $102.97M to $121.47M.
- What is the long-term trend for Cytek Biosciences, Inc.'s total liabilities?
- Over 5 years (2020 to 2025), Cytek Biosciences, Inc.'s total liabilities has grown at a 23.5% compound annual growth rate (CAGR), from $41.69M to $119.8M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.